Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table summarizes purchases of our own equity securities during the three months ended February 28, 2026 (dollars in thousands, except per share amounts):
Period Total Number of Shares Purchased Average Price Paid per Share
Dollar Value of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares That May Yet be Purchased Under the Plans or Programs (a)
December 1-31
— $ — $ — $ 900,000
January 1-31
291,584 57.51 15,624 884,376
February 1-28
831,963 61.83 34,376 850,000
Total 1,123,547 $ 60.71 $ 50,000
(a) On October 9, 2025, our board of directors authorized us to repurchase up to $1.00 billion of our outstanding common stock. As of November 30, 2025, there was $900.0 million of remaining availability under this share repurchase authorization. In the 2026 first quarter, we repurchased 843,339 shares of our common stock on the open market pursuant
46
to this authorization at a total cost of $50.0 million. As of February 28, 2026, we were authorized to repurchase up to $850.0 million of our outstanding common stock.
The total number of shares purchased and average price paid per share in the above table includes previously issued shares delivered to us by employees to satisfy withholding taxes on the vesting of restricted stock in January 2026 and PSUs in February 2026, as described in Note 18 –Stockholders’ Equity in the Notes to Consolidated Financial Statements in this report. These transactions are not considered repurchases under the board of directors’ authorization.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.